GlassScriptPhysician profile
Ajay Sanan
NPI 1295799369
$7,841.10
in general payments reported to CMS, 2019-2025
27 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,593 · 2020: $864 · 2021: $952 · 2022: $902 · 2023: $1,292 · 2024: $1,183 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,512 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,512.21 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,928.85 | 2019-2025 | Clareon, Tryptyr, Acrysof Iq Panoptix Uv Iol |
| Glaukos Corporation | $636.31 | 2019-2025 | Idose, Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Carl Zeiss Meditec, INC. | $606.35 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $537.47 | 2019-2023 | |
| Dompe US, INC. | $502.22 | 2019-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $441.59 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $425.58 | 2019-2025 | Omni Surgical System |
| Rxsight INC | $352.63 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $319.52 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $238.21 | 2019-2022 | |
| Abbvie INC. | $236.92 | 2022-2024 | Durysta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $203.97 | 2019 | |
| Bausch & Lomb Americas INC. | $166.68 | 2022-2023 | Xiidra, Miebo |
| Aerie Pharmaceuticals, INC. | $161.27 | 2019 | |
| Kala Pharmaceuticals, INC. | $154.13 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $146.31 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $143.32 | 2019-2022 | |
| Ocular Therapeutix, INC. | $125.00 | 2024 | Dextenza |
| Omeros Corporation | $124.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $115.54 | 2019-2022 | |
| New World Medical,INC. | $84.00 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $61.47 | 2025 | |
| Harrow Eye, LLC | $59.80 | 2025 | Vevye |
| Akorn Operating Company LLC | $21.12 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Merz North America, INC. | $15.36 | 2023 | Xeomin |
| Shire North American Group INC | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Sanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.